Published in Dalton Trans on June 23, 2005
Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity. J Biol Inorg Chem (2005) 1.17
Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor. J Med Chem (2009) 1.04
Impact of bidentate chelators on lipophilicity, stability, and biodistribution characteristics of cationic 99mTc-nitrido complexes. Bioconjug Chem (2007) 0.93
3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition. J Med Chem (2013) 0.87
Efficient synthesis of 5-amido-3-hydroxy-4-pyrones as inhibitors of matrix metalloproteinases. Org Lett (2007) 0.82
Chemical and functional properties of metal chelators that mobilize copper to elicit fungal killing of Cryptococcus neoformans. Metallomics (2016) 0.75
Clinical practice guideline: hoarseness (dysphonia). Otolaryngol Head Neck Surg (2009) 2.31
Brilliant Sm, Eu, Tb, and Dy chiral lanthanide complexes with strong circularly polarized luminescence. J Am Chem Soc (2007) 2.14
Postsynthetic modification of metal-organic frameworks. Chem Soc Rev (2009) 1.93
Stable lanthanide luminescence agents highly emissive in aqueous solution: multidentate 2-hydroxyisophthalamide complexes of Sm(3+), Eu(3+), Tb(3+), Dy(3+). J Am Chem Soc (2003) 1.91
To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition. Biochim Biophys Acta (2009) 1.48
Zinc-binding groups modulate selective inhibition of MMPs. ChemMedChem (2008) 1.47
New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups. J Am Chem Soc (2004) 1.46
The design of inhibitors for medicinally relevant metalloproteins. ChemMedChem (2007) 1.44
Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. J Am Coll Surg (2007) 1.41
Postsynthetic modification of metal-organic frameworks--a progress report. Chem Soc Rev (2010) 1.40
Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors. Inorg Chem (2003) 1.35
Signatures of molecular magnetism in single-molecule transport spectroscopy. Nano Lett (2006) 1.30
Single-molecule magnets: a new family of Mn(12) clusters of formula [Mn(12)O(8)X(4)(O(2)CPh)(8)L(6)]. J Am Chem Soc (2002) 1.29
Hydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approach. Angew Chem Int Ed Engl (2010) 1.29
Potent, selective pyrone-based inhibitors of stromelysin-1. J Am Chem Soc (2005) 1.28
Metal binding studies and EPR spectroscopy of the manganese transport regulator MntR. Biochemistry (2006) 1.28
Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma. J Clin Invest (2005) 1.24
A bioinorganic perspective on matrix metalloproteinase inhibition. Curr Top Med Chem (2004) 1.18
Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity. J Biol Inorg Chem (2005) 1.17
Identifying chelators for metalloprotein inhibitors using a fragment-based approach. J Med Chem (2010) 1.15
A new role for old ligands: discerning chelators for zinc metalloproteinases. J Am Chem Soc (2006) 1.13
Postsynthetic ligand and cation exchange in robust metal-organic frameworks. J Am Chem Soc (2012) 1.08
Evaluation and binding-mode prediction of thiopyrone-based inhibitors of anthrax lethal factor. ChemMedChem (2006) 1.05
Characterization and structure of the manganese-responsive transcriptional regulator ScaR. Biochemistry (2009) 1.04
Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor. J Med Chem (2009) 1.04
Chelator fragment libraries for targeting metalloproteinases. ChemMedChem (2010) 1.02
Investigating the selectivity of metalloenzyme inhibitors. J Med Chem (2013) 0.99
Fast magnetization tunneling in tetranickel(II) single-molecule magnets. Inorg Chem (2006) 0.99
Exchange-biased quantum tunnelling in a supramolecular dimer of single-molecule magnets. Nature (2002) 0.99
2.4-A crystal structure of the asymmetric platinum complex [Pt(ammine)(cyclohexylamine)]2+ bound to a dodecamer DNA duplex. J Biol Chem (2002) 0.99
Metal-induced structural organization and stabilization of the metalloregulatory protein MntR. Biochemistry (2005) 0.98
Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors. Chem Commun (Camb) (2011) 0.98
DNA-binding and oligomerization studies of the manganese(II) metalloregulatory protein MntR from Bacillus subtilis. Biochemistry (2003) 0.98
Moisture-resistant and superhydrophobic metal-organic frameworks obtained via postsynthetic modification. J Am Chem Soc (2010) 0.97
From sensors to silencers: quinoline- and benzimidazole-sulfonamides as inhibitors for zinc proteases. J Am Chem Soc (2010) 0.97
Using model complexes to augment and advance metalloproteinase inhibitor design. Inorg Chem (2004) 0.96
Postsynthetic covalent modification of a neutral metal-organic framework. J Am Chem Soc (2007) 0.95
Systematic functionalization of a metal-organic framework via a postsynthetic modification approach. J Am Chem Soc (2008) 0.94
Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. J Am Chem Soc (2006) 0.94
Squamous cell carcinoma of the oropharynx and hypopharynx. Otolaryngol Clin North Am (2005) 0.93
Postsynthetic modification: a versatile approach toward multifunctional metal-organic frameworks. Inorg Chem (2009) 0.92
Enantiopure vs. racemic metalloligands: impact on metal-organic framework structure and synthesis. Chem Commun (Camb) (2007) 0.92
Accessing postsynthetic modification in a series of metal-organic frameworks and the influence of framework topology on reactivity. Inorg Chem (2009) 0.92
Addressing lead toxicity: complexation of lead(II) with thiopyrone and hydroxypyridinethione O,S mixed chelators. Inorg Chem (2004) 0.92
Observing the growth of metal-organic frameworks by in situ liquid cell transmission electron microscopy. J Am Chem Soc (2015) 0.91
Enzymatic activation of a matrix metalloproteinase inhibitor. Chem Commun (Camb) (2010) 0.91
A chiral, heterometallic metal-organic framework derived from a tris(chelate) coordination complex. Chem Commun (Camb) (2005) 0.90
Compliance and quality of life in patients on prescribed voice rest. Otolaryngol Head Neck Surg (2011) 0.90
Conformational studies of the manganese transport regulator (MntR) from Bacillus subtilis using deuterium exchange mass spectrometry. J Biol Inorg Chem (2007) 0.90
Emerging trends in metalloprotein inhibition. Dalton Trans (2011) 0.89
A novel heterocyclic atom exchange reaction with Lawesson's reagent: a one-pot synthesis of dithiomaltol. Chem Commun (Camb) (2005) 0.89
Engineering a metal-organic framework catalyst by using postsynthetic modification. Angew Chem Int Ed Engl (2009) 0.89
Tandem modification of metal-organic frameworks by a postsynthetic approach. Angew Chem Int Ed Engl (2008) 0.88
Elucidating drug-metalloprotein interactions with tris(pyrazolyl)borate model complexes. Inorg Chem (2002) 0.88
Preparation techniques for the injection of human autologous cartilage: an ex vivo feasibility study. Laryngoscope (2008) 0.88
Antagonism of a zinc metalloprotease using a unique metal-chelating scaffold: tropolones as inhibitors of P. aeruginosa elastase. Chem Commun (Camb) (2013) 0.88
Metal complexes of the trans-influencing ligand thiomaltol. Inorg Chem (2003) 0.88
Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors. Chem Commun (Camb) (2012) 0.88
Probing chelation motifs in HIV integrase inhibitors. Proc Natl Acad Sci U S A (2012) 0.87
Isoreticular synthesis and modification of frameworks with the UiO-66 topology. Chem Commun (Camb) (2010) 0.87
From model complexes to metalloprotein inhibition: a synergistic approach to structure-based drug discovery. Angew Chem Int Ed Engl (2003) 0.87
Nanomodulation of molecular nanomagnets. Inorg Chem (2009) 0.85
Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide. J Biol Inorg Chem (2010) 0.85
3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the Pseudomonas aeruginosa Virulence Factor LasB. ACS Med Chem Lett (2012) 0.85
Topological control in heterometallic metal-organic frameworks by anion templating and metalloligand design. J Am Chem Soc (2006) 0.83
Generating reactive MILs: isocyanate- and isothiocyanate-bearing MILs through postsynthetic modification. Angew Chem Int Ed Engl (2010) 0.83
Magnetic quantum tunneling: insights from simple molecule-based magnets. Dalton Trans (2010) 0.83
Modulating metal-organic frameworks to breathe: a postsynthetic covalent modification approach. J Am Chem Soc (2009) 0.83
A macrophage cell model for selective metalloproteinase inhibitor design. Chembiochem (2008) 0.83
Enhanced photochemical hydrogen production by a molecular diiron catalyst incorporated into a metal-organic framework. J Am Chem Soc (2013) 0.83
A mononuclear Fe(III) single molecule magnet with a 3/2↔5/2 spin crossover. J Am Chem Soc (2012) 0.83
Reusable oxidation catalysis using metal-monocatecholato species in a robust metal-organic framework. J Am Chem Soc (2014) 0.83
Efficient synthesis of 5-amido-3-hydroxy-4-pyrones as inhibitors of matrix metalloproteinases. Org Lett (2007) 0.82
Use of AlloDerm in type I tympanoplasty: a comparison with native tissue grafts. Laryngoscope (2005) 0.82
Disorder and intermolecular interactions in a family of tetranuclear Ni(II) complexes probed by high-frequency electron paramagnetic resonance. Inorg Chem (2008) 0.82
Covalent modification of a metal-organic framework with isocyanates: probing substrate scope and reactivity. Chem Commun (Camb) (2008) 0.82
Coherent manipulation and decoherence of s=10 single-molecule magnets. Phys Rev Lett (2009) 0.82
Tuning the adsorption properties of UiO-66 via ligand functionalization. Langmuir (2012) 0.81
Photochemical activation of a metal-organic framework to reveal functionality. Angew Chem Int Ed Engl (2010) 0.81
Evaluating prodrug strategies for esterase-triggered release of alcohols. ChemMedChem (2013) 0.81
Model complexes of cobalt-substituted matrix metalloproteinases: tools for inhibitor design. Inorg Chem (2006) 0.81
Tandem postsynthetic modification of metal-organic frameworks using an inverse-electron-demand Diels-Alder reaction. Inorg Chem (2011) 0.81
Uranium(III) complexes with bulky aryloxide ligands featuring metal-arene interactions and their reactivity toward nitrous oxide. Inorg Chem (2013) 0.81
Quantum tunneling of magnetization in a new [Mn18]2+ single-molecule magnet with s = 13. J Am Chem Soc (2002) 0.80
Luminescent dipyrrinato complexes of trivalent group 13 metal ions. Inorg Chem (2006) 0.80
Photocatalytic CO2 reduction by a mixed metal (Zr/Ti), mixed ligand metal-organic framework under visible light irradiation. Chem Commun (Camb) (2015) 0.80
Bidentate Zinc chelators for alpha-carbonic anhydrases that produce a trigonal bipyramidal coordination geometry. ChemMedChem (2010) 0.80
A robust, catalytic metal-organic framework with open 2,2'-bipyridine sites. Chem Commun (Camb) (2014) 0.80
Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship. Bioorg Med Chem Lett (2009) 0.80
Synthesis, breathing, and gas sorption study of the first isoreticular mixed-linker phosphonate based metal-organic frameworks. Chem Commun (Camb) (2013) 0.79
Photoluminescent Mn4 single-molecule magnet. Inorg Chem (2008) 0.79
Illuminating metal-ion sensors: benzimidazolesulfonamide metal complexes. Inorg Chem (2010) 0.79
Evaluation of heterogeneous metal-organic framework organocatalysts prepared by postsynthetic modification. Inorg Chem (2010) 0.79
Metalloprotein-inhibitor binding: human carbonic anhydrase II as a model for probing metal-ligand interactions in a metalloprotein active site. Inorg Chem (2013) 0.79
Preparation and characterization of asymmetric alpha-alkoxy dipyrrin ligands and their metal complexes. Dalton Trans (2007) 0.79
'Unconventional' coordination chemistry by metal chelating fragments in a metalloprotein active site. J Am Chem Soc (2014) 0.79
Heterometallic metal-organic frameworks based on tris(dipyrrinato) coordination complexes. Inorg Chem (2005) 0.78